A study by Park et al (17) reported that in 17 primary HCC tumor samples and 18 HCC cell lines, only one missense mutation (Val991Ile) in DLC1 was detected, namely in the START domain in the Hep40 cell line. This evidence concerns the gene DLC1 and neoplasm.